AAAAAA

   
Results: 1-15 |
Results: 15
Intravenous basic fibroblast growth factor produces a persistent reductionin infarct volume following permanent focal ischemia in rats
Authors: Sugimori, H Speller, H Finklestein, SP
Citation: H. Sugimori et al., Intravenous basic fibroblast growth factor produces a persistent reductionin infarct volume following permanent focal ischemia in rats, NEUROSCI L, 300(1), 2001, pp. 13-16
Intravenous basic fibroblast growth factor (bFGF) decreases DNA fragmentation and prevents downregulation of Bcl-2 expression in the ischemic brain following middle cerebral artery occlusion in rats
Authors: Ay, I Sugimori, H Finklestein, SP
Citation: I. Ay et al., Intravenous basic fibroblast growth factor (bFGF) decreases DNA fragmentation and prevents downregulation of Bcl-2 expression in the ischemic brain following middle cerebral artery occlusion in rats, MOL BRAIN R, 87(1), 2001, pp. 71-80
Recommendations for clinical trial evaluation of acute stroke therapies - Stroke Therapy Academic Industry Roundtable II (STAIR-II)
Authors: Albers, GW Bogousslavsky, J Bozik, MA Brass, LM Broderick, JP Fisher, M Goldstein, LB Salazar-Grueso, E Akitsuki, S Aranko, K Ashwood, T Atkinson, RP Bell, RD Brott, TG Cady, WJ Caplan, LR Coggins, S Cramer, S Cyrus, P Dayno, J Easton, JD Elliott, PJ Finklestein, SP Furlan, AJ Gamzu, E Glasky, MS Gordon, K Gorelick, PB Greenwood, DT Grotta, JC Gunn, K Hachinski, V Hacke, W Hall, ED Hsu, CY Humphreys, DM Ishikawa, H Jacobs, AJ Kaste, M Koroshetz, WJ Krams, M Lauritano, AA Leclerc, J Lees, KR Lesko, L Levine, SR Levy, DE Li, FH Lyden, PD Masayasu, H McDermott, J Meibach, RC Meya, U Miyairi, K Niidome, T Oeda, J Poole, RM Ron, ES Sacco, RL Saltarelli, MD Shimizu, K Shook, BJ Soehngen, M Soehngen, W Stamler, DA Styren, SD Teal, PA Tilley, BC Traystman, RJ Walker, MD Wallin, BA Warach, S Ward, DP Wessel, TC Wettstein, J
Citation: Gw. Albers et al., Recommendations for clinical trial evaluation of acute stroke therapies - Stroke Therapy Academic Industry Roundtable II (STAIR-II), STROKE, 32(7), 2001, pp. 1598-1606
NXY-059, a free radical-trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species - Comment
Authors: Finklestein, SP
Citation: Sp. Finklestein, NXY-059, a free radical-trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species - Comment, STROKE, 32(1), 2001, pp. 198-198
Functional magnetic resonance imaging of reorganization in rat brain afterstroke
Authors: Dijkhuizen, RM Ren, JM Mandeville, JB Wu, ON Ozdag, FM Moskowitz, MA Rosen, BR Finklestein, SP
Citation: Rm. Dijkhuizen et al., Functional magnetic resonance imaging of reorganization in rat brain afterstroke, P NAS US, 98(22), 2001, pp. 12766-12771
Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia - Editorial comment
Authors: Finklestein, SP
Citation: Sp. Finklestein, Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia - Editorial comment, STROKE, 31(9), 2000, pp. 2217-2217
Delayed systemic administration of PACAP38 is neuroprotective in transientmiddle cerebral artery occlusion in the rat - Comment
Authors: Finklestein, SP
Citation: Sp. Finklestein, Delayed systemic administration of PACAP38 is neuroprotective in transientmiddle cerebral artery occlusion in the rat - Comment, STROKE, 31(6), 2000, pp. 1417-1417
A pilot study of somatotopic mapping after cortical infarct
Authors: Cramer, SC Moore, CI Finklestein, SP Rosen, BR
Citation: Sc. Cramer et al., A pilot study of somatotopic mapping after cortical infarct, STROKE, 31(3), 2000, pp. 668-671
Cerebral ischemia
Authors: Segal, AZ Finklestein, SP
Citation: Az. Segal et Sp. Finklestein, Cerebral ischemia, ANGIOGENESIS IN HEALTH AND DISEASE, 2000, pp. 477-488
Potential usefulness of basic fibroblast growth factor as a treatment for stroke
Authors: Ay, H Ay, I Koroshetz, WJ Finklestein, SP
Citation: H. Ay et al., Potential usefulness of basic fibroblast growth factor as a treatment for stroke, CEREB DIS, 9(3), 1999, pp. 131-135
Basic fibroblast growth factor enhances axonal sprouting after cortical injury in rats
Authors: Ramirez, JJ Finklestein, SP Keller, J Abrams, W George, MN Parakh, T
Citation: Jj. Ramirez et al., Basic fibroblast growth factor enhances axonal sprouting after cortical injury in rats, NEUROREPORT, 10(6), 1999, pp. 1201-1204
Basic fibroblast growth factor does not prolong survival in a transgenic model of familial amyotrophic lateral sclerosis
Authors: Upton-Rice, MN Cudkowicz, ME Warren, L Mathew, RK Ren, JM Finklestein, SP Brown, RH
Citation: Mn. Upton-rice et al., Basic fibroblast growth factor does not prolong survival in a transgenic model of familial amyotrophic lateral sclerosis, ANN NEUROL, 46(6), 1999, pp. 934-934
Activation of distinct motor cortex regions during ipsilateral and contralateral finger movements
Authors: Cramer, SC Finklestein, SP Schaechter, JD Bush, G Rosen, BR
Citation: Sc. Cramer et al., Activation of distinct motor cortex regions during ipsilateral and contralateral finger movements, J NEUROPHYS, 81(1), 1999, pp. 383-387
Intracisternal antisense oligonucleotide to growth associated protein-43 blocks the recovery-promoting effects of basic fibroblast growth factor after focal stroke
Authors: Kawamata, T Ren, JM Cha, JH Finklestein, SP
Citation: T. Kawamata et al., Intracisternal antisense oligonucleotide to growth associated protein-43 blocks the recovery-promoting effects of basic fibroblast growth factor after focal stroke, EXP NEUROL, 158(1), 1999, pp. 89-96
Reparative approaches: Growth factors and other pharmacological treatments
Authors: Cramer, SC Finklestein, SP
Citation: Sc. Cramer et Sp. Finklestein, Reparative approaches: Growth factors and other pharmacological treatments, STROKE THERAPY, 1999, pp. 321-336
Risultati: 1-15 |